Rat IL1R1 Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-Rat IL1R1 antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityRat IL1R1
Clonemonoclonal
Host SpeciesRabbit
Reactive Speciesrat
IsotypeIgG
Formatunconjugated
Size0.06 mL, 0.12 mL, 0.2 mL
Concentrationn/a
ApplicationsELISA (EIA)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionInterleukin 1 receptor, type I (IL-1R1) also known as CD121a (Cluster of Differentiation 121a), is an interleukin receptor. IL-1R1/CD121a is a cytokine receptor that belongs to the interleukin 1 receptor family. This protein is a receptor for interleukin alpha (IL1A), interleukin beta (IL1B), and interleukin 1 receptor, type I (IL1R1/IL1RA). IL-1R1/CD121a is an important mediator involved in many cytokine induced immune and inflammatory responses. This protein has been characterized by pharmacological and molecular techniques in the mouse brain. The spindle-shaped astrocytes enclose the wound, separating the healthy from damaged neural tissue. The shape change and subsequent repair processes are IL-1beta activity-dependent, acting through t
ImmunogenImmunogen: Recombinant Rat IL-1R1/CD121a protein Buffer: 0.2 mum filtered solution in PBS with 5% trehalose
Other Names[interleukin-1 receptor type 1 isoform 6; Interleukin-1 receptor type 1; interleukin-1 receptor type 1; interleukin 1 receptor type 1; CD121 antigen-like family member A; Interleukin-1 receptor alpha; IL-1R-alpha]
Gene, Accession #[IL1R1 ], Gene ID: 3554
Catalog #MBS2544698
Price$215, $330, $500
Order / More InfoRat IL1R1 Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.